Zheng Liu

10PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Powder and particle technologyInnate immunityAnimal protection (incl. pests and pathogens)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 06, 2026
3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

|Dec 09, 2024
Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids.

Ke Li, Xing Hu, Xin-Yi Tu

|Dec 20, 2023
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine.

Xing Hu, Mao-Ying Xian, Xi-Feng Wang

|Aug 31, 2022
A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses.

Ya-Qian Li, Cheng Yan, Xi-Feng Wang

|Jul 19, 2021
Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist.

Xi-Feng Wang, Meng-Jia Zhang, Na He

|Feb 04, 2021
Synthesis and Evaluation of Liposomal Anti-GM3 Cancer Vaccine Candidates Covalently and Noncovalently Adjuvanted by αGalCer.

Xu-Guang Yin, Jie Lu, Jian Wang

Pageof 2

Frequent Collaborators

5 joint publications

Jun Guo

1 joint publications

Guang-Fu Yang

1 joint publications

Courtney C Aldrich

1 joint publications

Jian Wang